(Q34790451)

4 August 2017

1 reference

title

The clinical effectiveness of aspirin desensitization in chronic rhinosinusitis (English)

1 reference

4 August 2017

1 reference

1 reference

1 reference

Adam N Williams

1

1 reference

4 August 2017

Katharine M Woessner

series ordinal

2

1 reference

4 August 2017

publication date

1 May 2008

1 reference

Current Allergy and Asthma Reports

4 August 2017

published in

1 reference

4 August 2017

volume

8

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

245-252

1 reference

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial

4 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11882-008-0041-7

Intolerance to aspirin. Clinical studies and consideration of its pathogenesis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11882-008-0041-7

Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics

21 January 2018

1 reference

12 December 2020

The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions

1 reference

12 December 2020

Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge

1 reference

12 December 2020

The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease

1 reference

12 December 2020

Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma

1 reference

12 December 2020

Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics

1 reference

12 December 2020

Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics

1 reference

12 December 2020

Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper

1 reference

12 December 2020

Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma

1 reference

12 December 2020

Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial

1 reference

12 December 2020

Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses

1 reference

12 December 2020

Prostaglandin E2 and aspirin-induced asthma

1 reference

12 December 2020

Does it make sense to "desens"? Aspirin desensitization in the treatment of chronic rhinosinusitis

1 reference

12 December 2020

Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice

1 reference

12 December 2020

Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease

1 reference

12 December 2020

Incidence of bronchoconstriction due to aspirin, azo dyes, non-azo dyes, and preservatives in a population of perennial asthmatics

1 reference

12 December 2020

Selection of patients for aspirin desensitization treatment

1 reference

12 December 2020

The diagnosis and management of sinusitis: a practice parameter update.

1 reference

12 December 2020

Aspirin intolerance in asthma *1, *2Detection by oral challenge

1 reference

12 December 2020

Clinical and pathologic perspectives on aspirin sensitivity and asthma

1 reference

12 December 2020

Medical and surgical considerations in patients with Samter's triad

1 reference

12 December 2020

Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes

1 reference

12 December 2020

Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes

1 reference

12 December 2020

Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease

1 reference

12 December 2020

Long-term effects of aspirin desensitization--treatment for aspirin-sensitive rhinosinusitis-asthma

1 reference

12 December 2020

Mechanisms of aspirin sensitivity

1 reference

12 December 2020

The natural history and clinical characteristics of aspirin-exacerbated respiratory disease

1 reference

12 December 2020

Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease

1 reference

12 December 2020

The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review

1 reference

12 December 2020

The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges

1 reference

12 December 2020

Refractory period to aspirin in a patient with aspirin-induced asthma

1 reference

12 December 2020

Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin

1 reference

12 December 2020

A controlled study of 9α,11β-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge

1 reference

12 December 2020

Pathogenesis, diagnosis, and treatment of aspirin intolerance

1 reference

12 December 2020

Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges

1 reference

12 December 2020

Intranasal treatment with lysine acetylsalicylate in patients with nasal polyposis

1 reference

12 December 2020

10.1007/S11882-008-0041-7

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1016040259

0 references

1 reference